Loading stock data…
Tempus AI, Inc. (TEM)
$58.31+2.17 (+3.87%)
After Hours$58.11-0.20 (-0.34%)· Last close Jun 29
Tempus AI, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Tempus AI, Inc. in the Healthcare sector is trading at $58.31 with a market capitalization of $8.5B. Wall Street consensus targets $66.53 (15 analysts), implying a +14.1% move over the next 12 months. The stock is currently 44% below its 52-week high of $104.32, remaining 8.2% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +14.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $348.12M↓ | $367.21M↑ | $334.21M↑ | $314.63M↑ | $255.74M |
| Gross Profit | $222.04M↓ | $237.71M↑ | $209.94M↑ | $195.04M↑ | $155.20M |
| Operating Income | -$84.71M↓ | -$61.41M↓ | -$61.00M↑ | -$61.77M↑ | -$68.69M |
| Net Income | -$125.92M↓ | -$54.17M↑ | -$79.98M↓ | -$42.84M↑ | -$68.04M |
Peer Comparison
JNJUNHPFE
Fundamentals
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytic...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.53B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-72.74%
Volume
Today's trading volume
7.59M
Recent News
Nancy Pelosi Has Added These 9 Stocks To Her Portfolio Since 2025, Including Three Magnificent Seven Names
Congresswoman and former Speaker of the House Nancy Pelosi (D-Calif.) is one of the most followed members of Congress when it comes to her disclosed stock and options trades. Here’s a look at the trades disclosed by Pelosi since the...
Tempus AI (TEM) is Amongst AI stocks Under $30 That Carry High Short Interest
Tempus AI Inc. (NASDAQ:TEM) is one of the 10 worst artificial intelligence stocks under $30 according to short sellers. During the first week of June, Tempus AI Inc. (NASDAQ:TEM) shared the impending clinical availability for its advanced sequencing test, xH. It detects oncologic targets within bone marrow and peripheral blood samples, based on whole-genome sequencing […]
Is Tempus AI, Inc. (TEM) Among the Best AI Drug Discovery Stocks to Buy According to Hedge Funds?
Tempus AI, Inc. (NASDAQ:TEM) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On. On June 11, 2026, Tempus AI, Inc. (NASDAQ:TEM) announced that a multi-center validation of its artificial intelligence ECG software for predicting one-year atrial fibrillation or flutter risk was published in Heart Rhythm. The company stated the […]
Redditors Think Tempus AI (TEM) Still Has 10X Potential
We just covered the 10 Stocks That Will 10X According to Social Media. Tempus AI (NASDAQ:TEM) ranks #7 (see 5 Stocks That Will 10X According to Social Media). Number of Hedge Fund Investors: 33 Tempus AI (NASDAQ:TEM) runs cancer diagnostic tests and sells the resulting data and AI tools to pharmaceutical companies and research institutions. […]
Tempus Al, Inc. (TEM) Opens Open-Source Digital Pathology Consortium
Tempus AI, Inc. (NASDAQ:TEM) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On June 3, Tempus AI, Inc. (NASDAQ:TEM) reported that it launched an open-source digital pathology consortium, alongside Yale New Haven Hospital and Memorial Sloan Kettering Cancer Center, aiming to build a scalable platform and viewer. Chief of Pathology […]